The KAZN Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HEK293T human embryonic kidney epithelial cell line. This product introduces targeted disruption of the KAZN gene, generating a heterogeneous pool of edited cells for loss-of-function analysis. As a polyclonal population, it reflects editing diversity and avoids the biases of single-cell clone isolation, offering a physiologically relevant model for studying kazrin-dependent pathways.
HEK293T cells are an adherent epithelial line originating from human embryonic kidney, extensively employed in biological research due to their high transfectability and expression of the SV40 large T antigen, which supports episomal plasmid replication. These properties make them a standard platform for lentivirus and retrovirus production, as well as cell adhesion, migration, and signaling studies. Their epithelial derivation and robust culture characteristics provide a suitable background for examining desmosome biology and cytoskeletal dynamics.
KAZN encodes kazrin, a periplakin-binding protein that localizes to desmosomes and coordinates cell-cell adhesion and cytoskeletal organization. Kazrin directly interacts with periplakin (PPL) and desmoplakin (DSP), integrating into a macromolecular complex that includes plakoglobin and keratin filaments to maintain epithelial integrity. Upstream, KAZN is regulated by miR-21 and Wnt pathway ligands such as WNT3A, while downstream, it modulates the actin cytoskeleton and adhesion complex assembly. CRISPR/Cas9-mediated disruption of KAZN is expected to impair desmosome formation, leading to compromised adhesion and altered epithelial morphology.
In HEK293T cells, KAZN knockout serves as a critical tool for investigating desmosome-dependent adhesion mechanisms frequently dysregulated in colorectal cancer, glioblastoma, and malignant pleural mesothelioma. Loss of kazrin may weaken cell-cell junctions, promoting a more migratory and invasive phenotype that recapitulates aspects of tumor progression. This model is valuable for elucidating the tumor-suppressive or oncogenic roles of KAZN and for screening agents that restore epithelial barrier integrity.
Researchers can employ Western blotting to monitor periplakin and desmoplakin levels, immunofluorescence to visualize desmosome markers, scratch wound healing and Transwell assays to assess migration and invasion, co-immunoprecipitation to probe protein interactions, and RNA-seq for transcriptional profiling. These applications support investigations into adhesion signaling, cancer cell behavior, and drug discovery targeting epithelial integrity. For additional technical information or assistance with experimental design, please reach out to Ascent Research.
